Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Treatment options for recurrent Clostridioides difficile infection (rCDI) are limited. Current standard of care has high recurrence rates (1)
It is as non-randomized, prospective, clinical phase II treatment trial studying RBX2660 (up to 2 doses of RBX2660, rectally administered) vs a closely-matched historical control cohort was used for comparison in adult patients with Clostridioides difficile infection (CDI) (recurrent) (≥ 2 recurrences of CDI after primary CDI episode, treated with standard antibiotics, ≥ 2 episodes of severe CDI requiring hospitalization) (1)
Number of Participants Who Were CDI-diarrhea Free Through 8 W…